Explore the full management transaction log of Dianthus Therapeutics, Inc. /DE/, a publicly traded company based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Market capitalisation: €4.5bn. The latest transaction was filed on 1 October 2024 (J). Among the most active insiders: Fairmount Funds Management LLC. All data is accessible without an account.
10
Insider Decl.
0
Thresholds
€1m
5 ops.
Buy Volume
·
0 ops.
Sell Volume
49Σ signal
Buys €1m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.